Long
SYN BUY/LONG FOMO ENTRY NOW READY! 0.59 to 1.97 by End 2021

TICKER CODE: SYN
Company Name: SYNTHETIC BIOLOGICS, INC
Industry: HEALTH TECHNOLOGY, BIOTECHNOLOGY
Position Proposed: BUY/LONG
FOMO ENTRY: NOW READY
Entry: BUY READY (0.5950)
1st Partial Take Profit: 1.4090 (AUG 2021-OCT 2021)
2nd Partial Take Profit: 1.9700 (DEC 2021- FEB 2022)
Expected Potential Full Take Profit: 5.9450 (END 2022 - Mid 2023)
Stop Loss: 0.3470
Technical Analysis
1. Large Inverted Head & Shoulder FORMING, Indicating a Potential BUY to Take Profit Levels
2. Flagpole & Falling Wedge FORMED, Indicating a Potential BUY to Take Profit Levels
3. Price ranges from Falling Wedge and Second Shoulder formation Coincide each other, Indicating Levels of a BUY Potential.
4. Fibonacci Expansion Levels indicate a Potential BUY to Golden zones (0.786-1.618).
5. Final Take Profit level indicated by Price Range Expansion and coinciding with NEXT RESISTANCE LEVELS. (5.9450-6.0000)
Company Name: SYNTHETIC BIOLOGICS, INC
Industry: HEALTH TECHNOLOGY, BIOTECHNOLOGY
Position Proposed: BUY/LONG
FOMO ENTRY: NOW READY
Entry: BUY READY (0.5950)
1st Partial Take Profit: 1.4090 (AUG 2021-OCT 2021)
2nd Partial Take Profit: 1.9700 (DEC 2021- FEB 2022)
Expected Potential Full Take Profit: 5.9450 (END 2022 - Mid 2023)
Stop Loss: 0.3470
Technical Analysis
1. Large Inverted Head & Shoulder FORMING, Indicating a Potential BUY to Take Profit Levels
2. Flagpole & Falling Wedge FORMED, Indicating a Potential BUY to Take Profit Levels
3. Price ranges from Falling Wedge and Second Shoulder formation Coincide each other, Indicating Levels of a BUY Potential.
4. Fibonacci Expansion Levels indicate a Potential BUY to Golden zones (0.786-1.618).
5. Final Take Profit level indicated by Price Range Expansion and coinciding with NEXT RESISTANCE LEVELS. (5.9450-6.0000)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.